COMPANY PROFILE

Checkmate Pharmaceuticals

Explore full profile

Developing a new approach for cancer immunotherapy

Cambridge, United StatesFounded 2015Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2020

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

At a glance

Status: Acquired
Founded: 2015
Headquarters: Cambridge, United States
Employees: 10
Open positions: None listed
Dealroom signal: 30.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Apr 2022	$250M	—	Regeneron Pharmaceuticals	↗
SERIES COther financing	Jun 2020	$85M	$340M	Novo Holdings · Sectoral Asset Management · Omega Funds · F-Prime	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Checkmate Pharmaceuticals website traffic

Latest recorded traffic for Checkmate Pharmaceuticals is 260 monthly website visits, down 7.1% over the last three months. Checkmate Pharmaceuticals's team declined 69.7% over the past year.

Latest monthly visits260 3-month web change-7.1% 1-year team growth-69.7%

Monthly website visitsOct 2017–Jun 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BIBioviva-scienceGene therapy and R&D company that targets cellular aging by developing new gene therapies to regenerate cells, muscles, and organs	United States	Operational	4	$250K	—
UDUniversal Medical Imaging DiagnosticOffers a holistic alternative and complementary approach to overall health that uses non-invasive, non-radioactive and painless imaging of the whole body	Los Angeles, United States	Operational
NHNavinata HealthNavinata Health is conveniently educating today's busy Physicians about innovative life-saving Therapies	Princeton, United States	Operational
PAPrecision Health AIPrecision Health AI is platform tech company that combines modern AI technology with best in class oncology data	New York City, United States	Operational
STSkyhawk TherapeuticsA drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression	Waltham, United States	Operational
OTOrbus TherapeuticsOrbus Therapeutics is dedicated to developing products that treat rare diseases	Palo Alto, United States	Operational
TBTeraFold BiologicsTeraFold Biologics is developing an integrated computational platform for discovery, modeling, and pre-clinical validation of alternative	San Francisco, United States	Operational
HBHarbour BioMedHarbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer	Cambridge, United States	Operational

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

VPvenBio Partners
SISofinnova Investments
SPSofinnova Partners
F-F-Prime

Series B and later9 investors entered at this stage

DCDecheng Capital
NSNovo Seeds
LCLongitude Capital
NHNovo Holdings
SMSectoral Asset Management
OFOmega Funds
MEMedicxi
BRBrightEdge
CPClough Capital Partners

Other known investors1 additional known investor

RPRegeneron Pharmaceuticals

Talent

Book a demo to see the people

Team profiled 13 named & role-tagged

Founders /100 quality score

Key operators 3 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Checkmate Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Checkmate Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.